Healthcare provider profile · identity verified

Kimberly Clay Hooper, D.O.

Family Practice · GAHANNA, OH · NPI 1720160716

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	561	158
Amlodipine Besylate	Amlodipine Besylate	397	118
Lisinopril	Lisinopril	248	74
Omeprazole	Omeprazole	230	69
Metoprolol Succinate	Metoprolol Succinate	227	57
Metformin Hcl Er	Metformin Hcl	205	57
Gabapentin	Gabapentin	197	50
Losartan Potassium	Losartan Potassium	190	55
Levothyroxine Sodium	Levothyroxine Sodium	168	44
Potassium Chloride	Potassium Chloride	156	42
Rosuvastatin Calcium	Rosuvastatin Calcium	131	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	128	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	17
Pantoprazole Sodium	Pantoprazole Sodium	120	40
Carvedilol	Carvedilol	118	39
Hydrochlorothiazide	Hydrochlorothiazide	116	38
Allopurinol	Allopurinol	108	28
Tramadol Hcl	Tramadol Hcl	108	20
Albuterol Sulfate Hfa	Albuterol Sulfate	105	45
Finasteride	Finasteride	102	29
Paroxetine Hcl	Paroxetine Hcl	97	22
Tamsulosin Hcl	Tamsulosin Hcl	97	32
Farxiga	Dapagliflozin Propanediol	93	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	85	14
Eliquis	Apixaban	81	21
Escitalopram Oxalate	Escitalopram Oxalate	81	26
Sertraline Hcl	Sertraline Hcl	80	24
Pioglitazone Hcl	Pioglitazone Hcl	76	19
Jardiance	Empagliflozin	75	15
Triamcinolone Acetonide	Triamcinolone Acetonide	71	38
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	23
Simvastatin	Simvastatin	68	19
Pravastatin Sodium	Pravastatin Sodium	65	17
Fluticasone Propionate	Fluticasone Propionate	64	24
Glimepiride	Glimepiride	64	16
Trazodone Hcl	Trazodone Hcl	64	18
Celecoxib	Celecoxib	60	21
Doxazosin Mesylate	Doxazosin Mesylate	60	15
Spironolactone	Spironolactone	60	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	16
Furosemide	Furosemide	54	19
Metformin Hcl	Metformin Hcl	53	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	13
Doxepin Hcl	Doxepin Hcl	40	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Clonazepam	Clonazepam	38	suppressed
Lamotrigine	Lamotrigine	37	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	36	12
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	15
Hydralazine Hcl	Hydralazine Hcl	34	12
Ozempic	Semaglutide	34	suppressed
Ezetimibe	Ezetimibe	33	12
Ketoconazole	Ketoconazole	33	11
Myrbetriq	Mirabegron	30	suppressed
Prednisone	Prednisone	30	21
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	11
Warfarin Sodium	Warfarin Sodium	28	suppressed
Linzess	Linaclotide	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Lyrica	Pregabalin	24	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Testosterone	Testosterone	18	suppressed
Famotidine	Famotidine	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Chlorthalidone	Chlorthalidone	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Pregabalin	Pregabalin	14	suppressed
Ramipril	Ramipril	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Atenolol	Atenolol	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Indapamide	Indapamide	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Torsemide	Torsemide	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Clomipramine Hcl	Clomipramine Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitroglycerin	Nitroglycerin	12	12
Primidone	Primidone	12	suppressed
Valsartan	Valsartan	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error